Optimizing Outcomes in Late-Onset Pompe Disease: Integrating New Therapies, Whole-Person Markers for Disease Monitoring, and Shared Decision-making Into Practice
With the approval of 2 new entities, recent advances in enzyme replacement therapy (ERT) have created a paradigm shift in which healthcare providers (HCPs) have gone...